Trial Profile
A Double-Blind, Placebo-Controlled, Randomized Trial of Pentoxifylline for Imbalance Secondary to Insufficient Microvascular Perfusion
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Apr 2021
Price :
$35
*
At a glance
- Drugs Pentoxifylline (Primary)
- Indications Tinnitus
- Focus Therapeutic Use
- 12 Apr 2021 Status changed from recruiting to completed.
- 25 Jul 2018 Planned End Date changed from 1 Jan 2020 to 1 Jan 2021.
- 16 Jun 2016 Planned End Date changed from 1 Jan 2019 to 1 Jan 2020.